Lumicitabine
Lumicitabine Uses, Dosage, Side Effects, Food Interaction and all others data.
Lumicitabine is under investigation in clinical trial NCT03010059 (A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations).
| Trade Name | Lumicitabine |
| Generic | Lumicitabine |
| Lumicitabine Other Names | ALS-008176, Lumicitabine |
| Type | |
| Formula | C18H25ClFN3O6 |
| Weight | Average: 433.86 Monoisotopic: 433.1415914 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Lumicitabine
